Bettina Jung: Methadon im Zellversuch beim Glioblastom unwirksam. In: DAZ.online. 1. März 2018 (deutsche-apotheker-zeitung.de [abgerufen am 2. Oktober 2018]).
M Kuhnert-Brandstätter, L. Friedl: Beitrag zur thermischen Analyse und zur Polymorphie optischer Antipoden: Pantolacton, Methadon und Usninsäure. In; Mikrochim. Acta 1979, Band 72, S. 97–110, doi:10.1007/BF01198052.
Friedemann Nauck et al.: Methadone as anticancer treatment: hype, hope, or hazard? In: Wiener Medizinische Wochenschrift. Band168, Nr.7-8, 1. Mai 2018, S.159–167, doi:10.1007/s10354-018-0623-5.
NS. Cai, C. Quiroz, J. Bonaventura et al.: Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. In: J. Clin. Invest. Band129, Heft 7, 2019, S.2730–2744, doi:10.1172/JCI126912, PMID 30913037, PMC 6597217 (freier Volltext) – (jci.org).
C B Eap, S Crettol, J-S Rougier, J Schläpfer, L Sintra Grilo: Stereoselective Block of hERG Channel by (S)-Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers. In: Clinical Pharmacology & Therapeutics. Band81, Nr.5, 28. Februar 2007, S.719–728, doi:10.1038/sj.clpt.6100120.
Tatjana Vatter et al.: Against Repurposing Methadone for Glioblastoma Therapy. In: Biomolecules. Band10, Nr.6, 17. Juni 2020, S.E917, doi:10.3390/biom10060917, PMID 32560384, PMC 7356722 (freier Volltext).
S. Wirz et al.: Einsatz von Methadon zur Unterstützung der onkologischen Therapie? In: Der Schmerz. Band31, Nr.1, 1. Februar 2017, S.2–4, doi:10.1007/s00482-016-0183-9.
Marieke H. J. van den Beuken-van Everdingen, Sander M. J. van Kuijk und Elbert A. Joosten: Response to the Article "Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids". In: Journal of Palliative Medicine. Band20, Nr.11, November 2017, S.1184–1185, doi:10.1089/jpm.2017.0301, PMID 28731784.
Bodo Haas et al.: Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent. In: Journal of Cancer Research and Clinical Oncology. Band147, Nr.3, 1. März 2021, S.779–792, doi:10.1007/s00432-020-03485-3, PMID 33315125, PMC 7872955 (freier Volltext).
Akhila Reddy et al.: Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids. In: Journal of Palliative Medicine. Band20, Nr.6, Juni 2017, S.656–661, doi:10.1089/jpm.2016.0316, PMID 27997283.
Philip J. Wiffen et al.: Opioids for cancer-related pain in children and adolescents. In: The Cochrane Database of Systematic Reviews. Band7, 19. Juli 2017, S.CD012564, doi:10.1002/14651858.CD012564.pub2, PMID 28722116.
S. Mercadante, A. Casuccio und L. Calderone: Rapid switching from morphine to methadone in cancer patients with poor response to morphine. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band17, Nr.10, Oktober 1999, S.3307–3312, doi:10.1200/JCO.1999.17.10.3307, PMID 10506634.
Melanie Güthle et al.: Eine Phase I/II Studie zur Therapie mit D,L-Methadon und mFOLFOX6 in der Behandlung des fortgeschrittenen kolorektalen Karzinoms: Die MEFOX Studie (AIO-KRK-0119). In: Zeitschrift für Gastroenterologie. Band59. Georg Thieme Verlag KG, August 2021, S.e185, doi:10.1055/s-0041-1733553.
Konstantin Brawanski et al.: Efficacy of D,L-methadone in the treatment of glioblastoma in vitro. In: CNS oncology. Band7, Nr.3, 1. Juli 2018, S.CNS18, doi:10.2217/cns-2018-0006, PMID 29916277, PMC 6200059 (freier Volltext).
Douglas Goldsmith et al. Methadone Folklore: Beliefs about Side Effects and Their Impact on Treatment. In: Human Organization, 43, 1984, S. 330, doi:10.17730/humo.43.4.64m061v484th3871.
Dana E. Hunt, Douglas S. Lipton, Douglas S. Goldsmith, David L. Strug, Barry Spunt: Substance Use & Misuse. Band 20, No. 11–12, 1985, S. 1751–1771, doi:10.3109/10826088509047261
Wayne A. Ray et al.: Out-of-hospital mortality among patients receiving methadone for noncancer pain. In: JAMA internal medicine. Band175, Nr.3, März 2015, S.420–427, doi:10.1001/jamainternmed.2014.6294, PMID 25599329, PMC 4346542 (freier Volltext).
W. R. Davis, B. D. Johnson: Prescription opioid use, misuse, and diversion among street drug users in New York City. In: Drug and alcohol dependence, Band 92, Nummer 1–3, Januar 2008, S. 267–276, doi:10.1016/j.drugalcdep.2007.08.008. PMID 17913395. PMC 2317747 (freier Volltext).
Patent US2443246: Preparation of certain diarylacetonitriles. Angemeldet am 9. Dezember 1946, veröffentlicht am 15. Juni 1948, Erfinder: August H. Homeyer, Janet S. Splitter (Mallinckrodt).
Patent US2644010: Salts of D-amidone with an optically active acid and process for resolving DL-amidone. Veröffentlicht am 30. Juni 1953, Erfinder: Eugene E. Howe, Max Tishler (MSD).
Patent US2983757: Resolution of DL-methadone. Veröffentlicht am 9. Mai 1961, Erfinder: Harold E. Zaugg (Abbott).
google.de
books.google.de
Foundation for a Drug-Free World: The Truth About Painkillers. In; Drug-Free World, S. 16. (eingeschränkte Vorschau in der Google-Buchsuche)
hexal.de
Methaddict® ist der patentiert Handelsname von Hexal
jci.org
NS. Cai, C. Quiroz, J. Bonaventura et al.: Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. In: J. Clin. Invest. Band129, Heft 7, 2019, S.2730–2744, doi:10.1172/JCI126912, PMID 30913037, PMC 6597217 (freier Volltext) – (jci.org).
Richard A. Rettig, Adam Yarmolinsky, Institute of Medicine (U.S.). Committee on Federal Regulation of Methadone Treatment: Federal regulation of methadone treatment. 1995.
nih.gov
ncbi.nlm.nih.gov
P. O. Wolff: On pethidine and methadone derivatives. In: Bulletin of the World Health Organization, Band 2, Nummer 2, 1949, S. 193–204. PMID 15409516. PMC 2553950 (freier Volltext).
C. C. Scott und K. K. Chen: The action of 1,1-diphenyl-1-(dimethylaminoisopropyl)-butanone-2, a potent analgesic agent. In: Federation proceedings, Band 5, Nummer 1, 1946, S. 201. PMID 20983210.
Strand MC, Ramaekers JG, Gjerde H, Mørland J, Vindenes V: Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions., J Clin Psychopharmacol. 2019 Sep/Oct;39(5), S. 489–493, PMID 31305338
R. Kronstrand, M. Forsman, M. Roman: Quantitative analysis of drugs in hair by UHPLC high resolution mass spectrometry., Forensic Sci Int. 2018 Feb;283, S. 9–15, PMID 29241093
M. Vandenbosch, T. Somers, E. Cuypers: Distribution of Methadone and Metabolites in Skeletal Tissue., J Anal Toxicol. 2018 Jul 1;42(6), S. 400–408, PMID 29490025
R. Bade, JM. White, C. Gerber: Qualitative and quantitative temporal analysis of licit and illicit drugs in wastewater in Australia using liquid chromatography coupled to mass spectrometry., Anal Bioanal Chem. 2018 Jan;410(2), S. 529–542, PMID 29214532
S. Ullah, S. Sandqvist, O. Beck: A liquid chromatography and tandem mass spectrometry method to determine 28 non-volatile drugs of abuse in exhaled breath., J Pharm Biomed Anal. 2018 Jan 30;148, S. 251–258, PMID 29059614
A. Ribeiro, M. Prata, C. Vaz, T. Rosado, J. Restolho, M. Barroso, Araújo Gallardo. ARTSE: Determination of methadone and EDDP in oral fluid using the dried saliva spots sampling approach and gas chromatography-tandem mass spectrometry., Anal Bioanal Chem. 2019 Apr;411(10), S. 2177–2187, PMID 30824966
YC. Hsu, BG. Chen, SC. Yang, YS. Wang, SP. Huang, MH. Huang, TJ. Chen, HC. Liu, DL. Lin, RH. Liu, AW. Jones: Methadone concentrations in blood, plasma, and oral fluid determined by isotope-dilution gas chromatography-mass spectrometry., Anal Bioanal Chem. 2013 May;405(12), S. 3921–3928, PMID 23090648
NS. Cai, C. Quiroz, J. Bonaventura et al.: Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids. In: J. Clin. Invest. Band129, Heft 7, 2019, S.2730–2744, doi:10.1172/JCI126912, PMID 30913037, PMC 6597217 (freier Volltext) – (jci.org).
Yutaka Oda, Evan D. Kharasch: Metabolism of Methadone andlevo-α-Acetylmethadol (LAAM) by Human Intestinal Cytochrome P450 3A4 (CYP3A4): Potential Contribution of Intestinal Metabolism to Presystemic Clearance and Bioactivation. In: J Pharmacol Exp Ther, 298(3), Sep 2001, S. 1021–1032. PMID 11504799.
E. F. McCance-Katz, P. Jatlow, P. M. Rainey: Effect of cocaine use on methadone pharmacokinetics in humans. In: Am J Addict., 19(1), Jan–Feb 2010, S. 47–52. PMID 20132121.
Tatjana Vatter et al.: Against Repurposing Methadone for Glioblastoma Therapy. In: Biomolecules. Band10, Nr.6, 17. Juni 2020, S.E917, doi:10.3390/biom10060917, PMID 32560384, PMC 7356722 (freier Volltext).
Marieke H. J. van den Beuken-van Everdingen, Sander M. J. van Kuijk und Elbert A. Joosten: Response to the Article "Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids". In: Journal of Palliative Medicine. Band20, Nr.11, November 2017, S.1184–1185, doi:10.1089/jpm.2017.0301, PMID 28731784.
Bodo Haas et al.: Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent. In: Journal of Cancer Research and Clinical Oncology. Band147, Nr.3, 1. März 2021, S.779–792, doi:10.1007/s00432-020-03485-3, PMID 33315125, PMC 7872955 (freier Volltext).
Akhila Reddy et al.: Overall Survival among Cancer Patients Undergoing Opioid Rotation to Methadone Compared to Other Opioids. In: Journal of Palliative Medicine. Band20, Nr.6, Juni 2017, S.656–661, doi:10.1089/jpm.2016.0316, PMID 27997283.
Philip J. Wiffen et al.: Opioids for cancer-related pain in children and adolescents. In: The Cochrane Database of Systematic Reviews. Band7, 19. Juli 2017, S.CD012564, doi:10.1002/14651858.CD012564.pub2, PMID 28722116.
S. Mercadante, A. Casuccio und L. Calderone: Rapid switching from morphine to methadone in cancer patients with poor response to morphine. In: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. Band17, Nr.10, Oktober 1999, S.3307–3312, doi:10.1200/JCO.1999.17.10.3307, PMID 10506634.
Konstantin Brawanski et al.: Efficacy of D,L-methadone in the treatment of glioblastoma in vitro. In: CNS oncology. Band7, Nr.3, 1. Juli 2018, S.CNS18, doi:10.2217/cns-2018-0006, PMID 29916277, PMC 6200059 (freier Volltext).
J. Stringer, C. Welsh und A. Tommasello: Methadone-associated Q-T interval prolongation and torsades de pointes. In: Am J Health Syst Pharm. 66(9), 1. Mai 2009, S. 825–833. PMID 19386945
Stallvik et al.: Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations. Drug And Alcohol Dependence, PMID 23084592
Wayne A. Ray et al.: Out-of-hospital mortality among patients receiving methadone for noncancer pain. In: JAMA internal medicine. Band175, Nr.3, März 2015, S.420–427, doi:10.1001/jamainternmed.2014.6294, PMID 25599329, PMC 4346542 (freier Volltext).
W. R. Davis, B. D. Johnson: Prescription opioid use, misuse, and diversion among street drug users in New York City. In: Drug and alcohol dependence, Band 92, Nummer 1–3, Januar 2008, S. 267–276, doi:10.1016/j.drugalcdep.2007.08.008. PMID 17913395. PMC 2317747 (freier Volltext).